Cargando…

Obstacles and opportunities in Chinese pharmaceutical innovation

BACKGROUND: Global healthcare innovation networks nowadays have expanded beyond developed countries with many developing countries joining the force and becoming important players. China, in particular, has seen a significant increase in the number of innovative firms and research organizations step...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Jingyun, Zhao, Junrui, Ung, Carolina Oi Lam, Hu, Yuanjia, Hu, Hao, Wang, Yitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366105/ https://www.ncbi.nlm.nih.gov/pubmed/28340579 http://dx.doi.org/10.1186/s12992-017-0244-6

Ejemplares similares

The opportunities for and obstacles against prevention: the example of Germany in the areas of tobacco and alcohol
por: Walter, Ulla, et al.
Publicado: (2010)

Community pharmacists’ perceptions about pharmaceutical service of over-the-counter traditional Chinese medicine: a survey study in Harbin of China
por: Song, Menghuan, et al.
Publicado: (2017)

Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation
por: Shi, Yun-Zhen, et al.
Publicado: (2014)

An Analysis of Chemical Ingredients Network of Chinese Herbal Formulae for the Treatment of Coronary Heart Disease
por: Ding, Fan, et al.
Publicado: (2015)

Is the United States Still Dominant in the Global Pharmaceutical Innovation Network?
por: Hu, Yuanjia, et al.
Publicado: (2013)

Community Pharmacists' Perceptions about Pharmaceutical Care of Traditional Medicine Products: A Questionnaire-Based Cross-Sectional Study in Guangzhou, China
por: Chen, Xi, et al.
Publicado: (2016)

Quality of Life as an outcome in Alzheimer's disease and other dementias- obstacles and goals
por: Riepe, Matthias W, et al.
Publicado: (2009)

Investigating the intention to receive the COVID-19 vaccination in Macao: implications for vaccination strategies
por: Ung, Carolina Oi Lam, et al.
Publicado: (2022)

Internationalization of traditional Chinese medicine: current international market, internationalization challenges and prospective suggestions
por: Lin, Annie Xianghong, et al.
Publicado: (2018)

'Linkage' pharmaceutical evergreening in Canada and Australia
por: Faunce, Thomas A, et al.
Publicado: (2007)

Models for financing the regulation of pharmaceutical promotion
por: Lexchin, Joel
Publicado: (2012)

An investigation Into Traditional Chinese Medicine Hospitals in China: Development Trend and Medical Service Innovation
por: Wang, Liang, et al.
Publicado: (2016)

Innovative health financing for refugees
por: Spiegel, Paul, et al.
Publicado: (2018)

Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
por: Jarosławski, Szymon, et al.
Publicado: (2011)

Why the MDGs need good governance in pharmaceutical systems to promote global health
por: Kohler, Jillian Clare, et al.
Publicado: (2014)

Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
por: Ooms, Gorik, et al.
Publicado: (2014)

Qualitative assessment of innovations in healthcare provision
por: Porzsolt, Franz, et al.
Publicado: (2009)

Paradoxes in carcinogenesis: New opportunities for research directions
por: Baker, Stuart G, et al.
Publicado: (2007)

Community-based knowledge translation: unexplored opportunities
por: Kothari, Anita, et al.
Publicado: (2011)

Integrating pathology and radiology disciplines: an emerging opportunity?
por: Sorace, James, et al.
Publicado: (2012)

Challenges and opportunities for ELSI early career researchers
por: Bell, Jessica, et al.
Publicado: (2016)

CETA and pharmaceuticals: impact of the trade agreement between Europe and Canada on the costs of prescription drugs
por: Lexchin, Joel, et al.
Publicado: (2014)

The ICMJE Recommendations and pharmaceutical marketing – strengths, weaknesses and the unsolved problem of attribution in publication ethics
por: Matheson, Alastair
Publicado: (2016)

Scientific progress: The role of innovative qualitative inquiries
por: Hellman, Matilda
Publicado: (2017)

Mutual learning and reverse innovation–where next?
por: Crisp, Nigel
Publicado: (2014)

Innovation in regulation of rapidly changing health markets
por: Bloom, Gerald, et al.
Publicado: (2014)

A model for ‘reverse innovation’ in health care
por: DePasse, Jacqueline W, et al.
Publicado: (2013)

Innovations in research ethics governance in humanitarian settings
por: Schopper, Doris, et al.
Publicado: (2015)

Challenges in cardiac device innovation: is neuroimaging an appropriate endpoint? Consensus from the 2013 Yale-UCL Cardiac Device Innovation Summit
por: Meller, Stephanie M, et al.
Publicado: (2013)

Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health
por: Mackey, Tim K, et al.
Publicado: (2013)

Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications
por: Liang, Zuanji, et al.
Publicado: (2021)

Translating three states of knowledge--discovery, invention, and innovation
por: Lane, Joseph P, et al.
Publicado: (2010)

Uncovering middle managers' role in healthcare innovation implementation
por: Birken, Sarah A, et al.
Publicado: (2012)

An innovative approach to developing the reflective skills of medical students
por: Henderson, Penny, et al.
Publicado: (2002)

Building an innovation system of medical devices in China: Drivers, barriers, and strategies for sustainability
por: Cheong, Sok Teng, et al.
Publicado: (2020)

The physician's unique role in preventing violence: a neglected opportunity?
por: Umhau, John C, et al.
Publicado: (2012)

Challenges and opportunities for the implementation of virological testing in resource-limited settings
por: Roberts, Teri, et al.
Publicado: (2012)

Food security for infants and young children: an opportunity for breastfeeding policy?
por: Salmon, Libby
Publicado: (2015)

Obesity and understudied minority children: existing challenges and opportunities in epidemiology
por: Quader, Zerleen S., et al.
Publicado: (2019)

The polypill approach – An innovative strategy to improve cardiovascular health in Europe
por: Fuster, Valentín, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e4hpr1r05dlkocpmgukqq9gqvp